Please Wait.....
Report
Ureteral Access Sheath Market By Type (Fr below 10, Fr 10-12, Fr 13-15) , By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 280 Pages I Allied Market Research
Ureteral Access Sheath Market
The ureteral access sheath market was valued at $1,293.6 million in 2023 and is estimated to reach $2,412.46 million by 2035, exhibiting a CAGR of 5.31% from 2024 to 2035
A ureteral access sheath is crucial equipment in urological procedures specifically used in interventions involving the urinary tract and kidneys. It is a flexible tube inserted into the ureter to form a path for other instruments, such as lasers and scopes, during minimally invasive surgeries such as ureteroscopy. The sheath enables repeated insertion and removal of instruments without causing any harm, which is beneficial in cases with multiple interventions or prolonged procedures. The easy access to the kidney and ureter offered by ureteral access sheath enables urologists to perform complex procedures with high precision and efficiency. According to research,ureteral access sheathlowersintraoperative intrarenal pressureand temperature by enhancing irrigation outflow during surgeries.
Increase in prevalence of kidney stone, developing healthcare infrastructure, and surge in adoption of minimally invasive procedures are the major drivers of the ureteral access sheath market. The cases of kidney stones have surged over the past few years due to unhealthy dietary habits and rise in obesity, dehydration, & metabolic disorders. As per a factsheet released by the Center of Disease Control and Prevention this year, around 6 million individuals are suffering from kidney stone in the U.S. Ureteral access sheaths play a crucial role in the treatment of such diseases, thereby witnessing a boost in demand.
However, the placement of ureteral access sheath is highly complex which requires significant training and practice. Incorrect placement usually leads to severe complications, hence constraining the market development. Moreover, there are several substitute approaches for the treatment of urinary diseases such as retrograde intrarenal surgery that do not use the sheath, hence limiting its adoption. Contrarily, according to a poster presented at the American Urological Association 2024 (AUA 2024) annual meeting, preoperative administration of tamsulosin, a medication which relaxes the prostate & bladder neck muscles, is able to successfully place the ureteral access sheath for treating kidney stones.
Segment Review
The global ureteral access sheath market is segmented into type, end user, and region. By type, the market is divided into Fr below 10, Fr 10-12, and Fr 13-15. On the basis of end user, it is classified into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the Fr below 10 segment dominated the market in 2023.
On the basis of end user, the specialty clinics segment acquired a high market share in 2023.
In North America, the market is robust, owing to mature healthcare system, and significant investments in R&D.
Competition Analysis
The major players operating in the ureteral access sheath market are Boston Scientific, Cook Medical, Coloplast Corp, Olympus Corporation, Karl Storz, Oscor Inc, Richard Wolf, Cogentix Medical, Becton, Dickinson and Company, and Envaste Ltd. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- Fr below 10
- Fr 10-12
- Fr 13-15
By End User
- Hospital
- Specialty Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Boston Scientific Corporation
- Cook Group
- Coloplast Corp.
- Olympus Corporation
- Oscor Inc.
- Karl Storz Endoscopy GmbH
- Richard Wolf GmbH
- COGENTIX MEDICAL
- Becton, Dickinson and Company
- Envaste Ltd
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: TRIAMCINOLONE MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Cream
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Injection
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Inhalers
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: TRIAMCINOLONE MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Eczema
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Dermatitis
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Allergies
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Psoriasis
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: TRIAMCINOLONE MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Overview
6.1.1 Market Size and Forecast, By Distribution Channel
6.2. Drug Stores
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hospitals Pharmacies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Online Pharmacies
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: TRIAMCINOLONE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By Distribution Channel
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Triamcinolone Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By Distribution Channel
7.2.7. Canada Triamcinolone Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By Distribution Channel
7.2.8. Mexico Triamcinolone Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By Distribution Channel
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By Distribution Channel
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Triamcinolone Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By Distribution Channel
7.3.7. France Triamcinolone Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By Distribution Channel
7.3.8. UK Triamcinolone Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By Distribution Channel
7.3.9. Italy Triamcinolone Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By Distribution Channel
7.3.10. Spain Triamcinolone Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By Distribution Channel
7.3.11. Rest of Europe Triamcinolone Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By Distribution Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By Distribution Channel
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Triamcinolone Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By Distribution Channel
7.4.7. China Triamcinolone Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By Distribution Channel
7.4.8. Australia Triamcinolone Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By Distribution Channel
7.4.9. India Triamcinolone Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By Distribution Channel
7.4.10. South Korea Triamcinolone Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By Distribution Channel
7.4.11. Rest of Asia-Pacific Triamcinolone Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By Distribution Channel
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By Distribution Channel
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Triamcinolone Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By Distribution Channel
7.5.7. Saudi Arabia Triamcinolone Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By Distribution Channel
7.5.8. South Africa Triamcinolone Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By Distribution Channel
7.5.9. Rest of LAMEA Triamcinolone Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Akorn Inc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Bristol Myers Squibb Company
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Cosette Pharmaceuticals, Inc
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Glenmark Pharmaceuticals
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Lupin
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Mylan N.V.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Novartis AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Sun Pharmaceutical Industries Limited
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Taro Pharmaceutical Industries
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Teva Pharmaceuticals
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. URETERAL ACCESS SHEATH MARKET FOR FR BELOW 10, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. URETERAL ACCESS SHEATH MARKET FOR FR 10-12, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. URETERAL ACCESS SHEATH MARKET FOR FR 13-15, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 6. URETERAL ACCESS SHEATH MARKET FOR HOSPITAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. URETERAL ACCESS SHEATH MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. URETERAL ACCESS SHEATH MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. URETERAL ACCESS SHEATH MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 13. U.S. URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 14. U.S. URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 15. CANADA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 16. CANADA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 18. MEXICO URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 25. FRANCE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. UK URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 27. UK URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. ITALY URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 29. ITALY URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 31. SPAIN URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 33. REST OF EUROPE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. CHINA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 40. CHINA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. AUSTRALIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 42. AUSTRALIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. INDIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 44. INDIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 46. SOUTH KOREA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 48. REST OF ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 53. BRAZIL URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 57. SOUTH AFRICA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 59. REST OF LAMEA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 61. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 62. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 63. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 64. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65. COOK GROUP: KEY EXECUTIVES
TABLE 66. COOK GROUP: COMPANY SNAPSHOT
TABLE 67. COOK GROUP: OPERATING SEGMENTS
TABLE 68. COOK GROUP: PRODUCT PORTFOLIO
TABLE 69. COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70. COLOPLAST CORP.: KEY EXECUTIVES
TABLE 71. COLOPLAST CORP.: COMPANY SNAPSHOT
TABLE 72. COLOPLAST CORP.: OPERATING SEGMENTS
TABLE 73. COLOPLAST CORP.: PRODUCT PORTFOLIO
TABLE 74. COLOPLAST CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. OLYMPUS CORPORATION: KEY EXECUTIVES
TABLE 76. OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 77. OLYMPUS CORPORATION: OPERATING SEGMENTS
TABLE 78. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
TABLE 79. OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80. OSCOR INC.: KEY EXECUTIVES
TABLE 81. OSCOR INC.: COMPANY SNAPSHOT
TABLE 82. OSCOR INC.: OPERATING SEGMENTS
TABLE 83. OSCOR INC.: PRODUCT PORTFOLIO
TABLE 84. OSCOR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85. KARL STORZ ENDOSCOPY GMBH: KEY EXECUTIVES
TABLE 86. KARL STORZ ENDOSCOPY GMBH: COMPANY SNAPSHOT
TABLE 87. KARL STORZ ENDOSCOPY GMBH: OPERATING SEGMENTS
TABLE 88. KARL STORZ ENDOSCOPY GMBH: PRODUCT PORTFOLIO
TABLE 89. KARL STORZ ENDOSCOPY GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. RICHARD WOLF GMBH: KEY EXECUTIVES
TABLE 91. RICHARD WOLF GMBH: COMPANY SNAPSHOT
TABLE 92. RICHARD WOLF GMBH: OPERATING SEGMENTS
TABLE 93. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
TABLE 94. RICHARD WOLF GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. COGENTIX MEDICAL: KEY EXECUTIVES
TABLE 96. COGENTIX MEDICAL: COMPANY SNAPSHOT
TABLE 97. COGENTIX MEDICAL: OPERATING SEGMENTS
TABLE 98. COGENTIX MEDICAL: PRODUCT PORTFOLIO
TABLE 99. COGENTIX MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 101. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 102. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 103. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 104. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. ENVASTE LTD: KEY EXECUTIVES
TABLE 106. ENVASTE LTD: COMPANY SNAPSHOT
TABLE 107. ENVASTE LTD: OPERATING SEGMENTS
TABLE 108. ENVASTE LTD: PRODUCT PORTFOLIO
TABLE 109. ENVASTE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL URETERAL ACCESS SHEATH MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF URETERAL ACCESS SHEATH MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN URETERAL ACCESS SHEATH MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALURETERAL ACCESS SHEATH MARKET
FIGURE 10. GLOBAL URETERAL ACCESS SHEATH MARKET SEGMENTATION, BY TYPE
FIGURE 11. URETERAL ACCESS SHEATH MARKET FOR FR BELOW 10, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. URETERAL ACCESS SHEATH MARKET FOR FR 10-12, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. URETERAL ACCESS SHEATH MARKET FOR FR 13-15, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL URETERAL ACCESS SHEATH MARKET SEGMENTATION, BY END USER
FIGURE 15. URETERAL ACCESS SHEATH MARKET FOR HOSPITAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. URETERAL ACCESS SHEATH MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. URETERAL ACCESS SHEATH MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 22. COMPETITIVE DASHBOARD
FIGURE 23. COMPETITIVE HEATMAP: URETERAL ACCESS SHEATH MARKET
FIGURE 24. TOP PLAYER POSITIONING, 2023
FIGURE 25. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 26. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 27. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 28. COOK GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. COOK GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. COOK GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. COLOPLAST CORP.: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. COLOPLAST CORP.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. COLOPLAST CORP.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. OLYMPUS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. OSCOR INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. OSCOR INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. OSCOR INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. KARL STORZ ENDOSCOPY GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. KARL STORZ ENDOSCOPY GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. KARL STORZ ENDOSCOPY GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. RICHARD WOLF GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. RICHARD WOLF GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. RICHARD WOLF GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. COGENTIX MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. COGENTIX MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. COGENTIX MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. ENVASTE LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. ENVASTE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. ENVASTE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security